Multiple Sclerosis Implementation Network (Registry)
Part of paid clinical trials in Cherry Hill, New Jersey.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT07415824
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with MS, and research leaders in MS and implementation science (IS) to learn, share, test, implement, and disseminate innovations that improve MS care, patient health, and quality of life. This ClinicalTrials.gov record pertains to the MSIN Patient Registry, which is a comprehensive database that integrates participants' electronic health records from various providers.
Key Dates
- Start date
- Apr 28, 2025
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 2,000 participants (estimated)
Arms
- Arm: Patients with Multiple Sclerosis
Primary Outcome Measure
Multiple sclerosis disability as assessed by the Patient-Determined Disease Steps (PDDS) Scale [ Time Frame: 5 years ]
Central Contacts
- Amanda Montague, EdM800-532-7667
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Multiple Sclerosis Association of America | Cherry Hill | New Jersey | 08034 | |
| The University of Texas at Austin | Austin | Texas | 78712 | |
| The University of Texas Health Science Center at Houston (UTHealth Houston) | Houston | Texas | 77030 |
Find similar trials in Cherry Hill, NJ
Related Studies
- NARCOMS Registry: A Multiple Sclerosis RegistryRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MSRecruiting · Kessler Foundation · West Orange, New Jersey
- Non-invasive BCI-controlled Assistive DevicesRecruiting · University of Texas at Austin · Austin, Texas